Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, November 30, 2017
[ Thu, Nov 30th 2017
] - WOPRAI
Wed, November 29, 2017
[ Wed, Nov 29th 2017
] - WOPRAI
[ Wed, Nov 29th 2017
] - WOPRAI
[ Wed, Nov 29th 2017
] - WOPRAI
[ Wed, Nov 29th 2017
] - WOPRAI
[ Wed, Nov 29th 2017
] - WOPRAI
[ Wed, Nov 29th 2017
] - WOPRAI
[ Wed, Nov 29th 2017
] - WOPRAI
[ Wed, Nov 29th 2017
] - WOPRAI
[ Wed, Nov 29th 2017
] - WOPRAI
[ Wed, Nov 29th 2017
] - WOPRAI
Tue, November 28, 2017
[ Tue, Nov 28th 2017
] - WOPRAI
[ Tue, Nov 28th 2017
] - WOPRAI
Mon, November 27, 2017
[ Mon, Nov 27th 2017
] - WOPRAI
[ Mon, Nov 27th 2017
] - WOPRAI
[ Mon, Nov 27th 2017
] - WOPRAI
[ Mon, Nov 27th 2017
] - WOPRAI
Edward Tenthoff Upgraded (ARWR) to Buy on, Nov 27th, 2017
Edward Tenthoff of Piper Sandler, Upgraded "Arrowhead Pharmaceuticals, Inc." (ARWR) to Buy on, Nov 27th, 2017.
Edward has made no other calls on ARWR in the last 4 months.
There is 1 other peer that has a rating on ARWR. Out of the 1 peers that are also analyzing ARWR, 0 agree with Edward's Rating of Hold.
This is the rating of the analyst that currently disagrees with Edward
- Y Katherine Xu of "William Blair" Upgraded from Hold to Buy on, Monday, September 18th, 2017
Similar Stocks and Investing Articles
[ Tue, Oct 31st 2017
] - WOPRAI
[ Tue, Apr 25th 2017
] - WOPRAI
[ Mon, Mar 27th 2017
] - WOPRAI
[ Wed, Nov 23rd 2016
] - WOPRAI
[ Fri, Aug 07th 2015
] - WOPRAI
[ Fri, Aug 07th 2015
] - WOPRAI
[ Mon, Jun 15th 2015
] - WOPRAI
[ Wed, Dec 18th 2013
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI